Synonyms: compound 11c [PMID: 2617910] | Ro 09-4889
Compound class:
Synthetic organic
Comment: RO0094889 is a prodrug dihydropyrimidine dehydrogenase (DPD) inhibitor that was developed by Hoffmann-La Roche [3]. RO0094889 is metabolised by enzymes secreted by tumours to produce the DPD inhibitor 5-vinyluracil. This leads to inhibition of DPD-mediated catabolic degradation of the 5-fluorouracil produced locally in tumours from capecitabine [2]. RO0094889 is orally active.
|
|
No information available. |
Summary of Clinical Use ![]() |
In Phase 1 evaluation in healthy subjects, single oral doses of RO094889 were well tolerated [1]. |